Head and Neck Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Effect of Hydrogen Water in Oral Mucositis in Head and Neck Cancer Patients After Therapy
Conditions: Head and Neck Cancer; Oral Mucositis; Pain; Quality of Life Intervention: Other: hydrogen water Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
Conditions: Metastatic Melanoma; Head and Neck Squamous Cell Carcinoma Interventions: Drug: GB1211; Drug: Pembrolizumab; Drug: Placebo Sponsors: Providence Health & Services; Providence Cancer Center; Providence Cancer Center, Earle A. Chiles Research Institute; Galecto Biotech AB Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
The Effect of Hydrogen Water in Oral Mucositis in Head and Neck Cancer Patients After Therapy
Conditions: Head and Neck Cancer; Oral Mucositis; Pain; Quality of Life Intervention: Other: hydrogen water Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
